Table 1. Baseline characteristics of 80 patients according to syndecan-1 epithelial and/or stromal expression.
| Variable | E+ (S+ou−) n=56 | E− (S+) n=24 | P-value |
|---|---|---|---|
| Age (years) | |||
| Median | 73 | 76 | |
| Range | (44–95) | (50–91) | 0.194 |
| Histologic size (mm) | |||
| Median | 20 | 21 | |
| Range | (10–40) | (7–35) | 0.458 |
| pT | |||
| pT1 | 32 | 12 | |
| pT2 | 24 | 12 | 0.628 |
| EE grade | |||
| I | 20 | 2 | |
| II | 30 | 15 | |
| III | 6 | 7 | 0.011 |
| ER | |||
| + | 53 | 24 | |
| − | 3 | 0 | 0.550 |
| PR | |||
| + | 47 | 20 | |
| − | 9 | 4 | 1.000 |
| Hormone therapy | |||
| No | 10 | 4 | |
| Yes | 46 | 20 | 1.000 |
| HER2 | |||
| 0, 1, 2 + | 54 | 23 | |
| 3+ | 2 | 1 | 1.000 |
E=epithelial staining (E+=56 patients, E−=24 patients); EE grade=Elston and Ellis grade; ER=oestrogen receptor; PR=progesterone receptor; S=stromal staining.